{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-28T12:23:12.640856+00:00",
  "news": [
    {
      "title": "Motley Fool Asset Management LLC Acquires 2,924 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNZy1tZktnX2d0dDkwQ0J0dFhWVG9iRTNkck1kOG02aDVYa25CeEMxdEU3VDVJX2ZEVEpOeDFNM3hsNzNmWE04VFdXM19KRVprSUFTMVhseVJGakRacFdGUXhKUk1HRXIxYWVlMXpSQ1RmdGxCT3VqTU03YmJ5OFFoMWlJRml2bS16VUVyUlpGMm8wVGhlTzhCY1ZCZXJXTndQd25kVkE2THpuSjZIZ1JGaElQR25yc2NNTV9OVmU3Vjg5SzVzdVF4UUFHbjg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxNZy1tZktnX2d0dDkwQ0J0dFhWVG9iRTNkck1kOG02aDVYa25CeEMxdEU3VDVJX2ZEVEpOeDFNM3hsNzNmWE04VFdXM19KRVprSUFTMVhseVJGakRacFdGUXhKUk1HRXIxYWVlMXpSQ1RmdGxCT3VqTU03YmJ5OFFoMWlJRml2bS16VUVyUlpGMm8wVGhlTzhCY1ZCZXJXTndQd25kVkE2THpuSjZIZ1JGaElQR25yc2NNTV9OVmU3Vjg5SzVzdVF4UUFHbjg?oc=5\" target=\"_blank\">Motley Fool Asset Management LLC Acquires 2,924 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-28T10:17:28+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen’s Repatha® Study: A Potential Game-Changer in Cardiovascular Care - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUkY4ZTFBWG1oa3NXOW13UG1DbmZSczRtTUJxM3FSZElfZ2d0VGZCaDQtQTFuMFVPdGZkRHZqMVI3a2liaUFCR3dGV2o1ZnByNlJuM1hta1BiUnFfS0J3RjVuVW14RmNqVWxPa0JWUWxxUGdaLVZQVU9fSVlFN0h6MXp2T3dGbEdFMkNvUEdFeGJvUXZFaURZZE9mM0ZKaS01NHhLUHc2ZmtITU83YUJiVkVHc01kTnJVVjNiMlB0MA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUkY4ZTFBWG1oa3NXOW13UG1DbmZSczRtTUJxM3FSZElfZ2d0VGZCaDQtQTFuMFVPdGZkRHZqMVI3a2liaUFCR3dGV2o1ZnByNlJuM1hta1BiUnFfS0J3RjVuVW14RmNqVWxPa0JWUWxxUGdaLVZQVU9fSVlFN0h6MXp2T3dGbEdFMkNvUEdFeGJvUXZFaURZZE9mM0ZKaS01NHhLUHc2ZmtITU83YUJiVkVHc01kTnJVVjNiMlB0MA?oc=5\" target=\"_blank\">Amgen’s Repatha® Study: A Potential Game-Changer in Cardiovascular Care</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-27T22:08:20+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-10-23T09:00:45+00:00",
      "source": "The New York Times"
    },
    {
      "title": "With questions surrounding its gastric cancer drug, Amgen fills in some gaps - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5\" target=\"_blank\">With questions surrounding its gastric cancer drug, Amgen fills in some gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-20T14:52:07+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Howard Capital Management Inc. Has $5.86 Million Stock Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPOUhKdzNFX195d3BQbGVHY2xtbDVKZkoxN1VlZVhUQ01Wc2FUMklneFQxZl9xY19OSmt0eDd2eU93cVVTV0VXemhGbDJxelpMOXVNWHhxNUpVVW1ZcmJRczNJSlAybnB5M1c3WGwzVDRUVTQ5RnhVY3FoU1Z0aVpwMThtU2tTNWgwc3NYOW1Ya2hkYkFYSHhGbjBaWUFJWUp6Vk4yWmg3b2JhZjlPTzZuZV80NVpTeTlrR2JudDBHamRieXJaczRzdWoxc2RIWGFYYWZDaFB3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPOUhKdzNFX195d3BQbGVHY2xtbDVKZkoxN1VlZVhUQ01Wc2FUMklneFQxZl9xY19OSmt0eDd2eU93cVVTV0VXemhGbDJxelpMOXVNWHhxNUpVVW1ZcmJRczNJSlAybnB5M1c3WGwzVDRUVTQ5RnhVY3FoU1Z0aVpwMThtU2tTNWgwc3NYOW1Ya2hkYkFYSHhGbjBaWUFJWUp6Vk4yWmg3b2JhZjlPTzZuZV80NVpTeTlrR2JudDBHamRieXJaczRzdWoxc2RIWGFYYWZDaFB3?oc=5\" target=\"_blank\">Howard Capital Management Inc. Has $5.86 Million Stock Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-28T10:46:11+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen’s Olpasiran Study: A Potential Game-Changer in Cardiovascular Treatment - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNU0RNMDB2cUNRVWg4NkhUTEtKMG5XNEVWMzIxRGp0VzY0cEFmX0h5ZVBHSlJ4X3lqMDkxUVhwc1Zib1pobWZoeDc5X3lFLUNMMHBuZFpPdWtyenpLMGhsaWtIVG1lUmFjUnhMbEl0YS1EYUN1YmxxTF9qSThaTmFJLW9pbHI1bDhVdDQzenF0OWJ0TFpNLVNBd2JjMC0zQkFKY3o0ZWlCTmpjQlZRUWZnd2FNVjlNQlEwNm4tSExHaUlrV3N1eHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxNU0RNMDB2cUNRVWg4NkhUTEtKMG5XNEVWMzIxRGp0VzY0cEFmX0h5ZVBHSlJ4X3lqMDkxUVhwc1Zib1pobWZoeDc5X3lFLUNMMHBuZFpPdWtyenpLMGhsaWtIVG1lUmFjUnhMbEl0YS1EYUN1YmxxTF9qSThaTmFJLW9pbHI1bDhVdDQzenF0OWJ0TFpNLVNBd2JjMC0zQkFKY3o0ZWlCTmpjQlZRUWZnd2FNVjlNQlEwNm4tSExHaUlrV3N1eHc?oc=5\" target=\"_blank\">Amgen’s Olpasiran Study: A Potential Game-Changer in Cardiovascular Treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-27T23:33:40+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Logan Capital Management Inc. Reduces Holdings in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRmE1XzRtdkF1cWVSaUtwSlhfQXgwTHQ2LTdjc3RwNjlPNk5KUWtPZVZVejktTXRTZEIzZ3h5QmRKd2lCaWl2MXIzdktNYnpxYm94N3g0eWtRRzNpcjZsMmdQR2gwQ1BRWlhnUTZzUjhyUVdxTklqMXdOTDgzTXZVS1ZvaWdPMWtQM2VoYVJzei1UYkpBR0lSM0t0OGhCdFZqTTNBU25kUzY2dkxQMi0zeDFKQmVsUTZkSGVxdUw2eUQtQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRmE1XzRtdkF1cWVSaUtwSlhfQXgwTHQ2LTdjc3RwNjlPNk5KUWtPZVZVejktTXRTZEIzZ3h5QmRKd2lCaWl2MXIzdktNYnpxYm94N3g0eWtRRzNpcjZsMmdQR2gwQ1BRWlhnUTZzUjhyUVdxTklqMXdOTDgzTXZVS1ZvaWdPMWtQM2VoYVJzei1UYkpBR0lSM0t0OGhCdFZqTTNBU25kUzY2dkxQMi0zeDFKQmVsUTZkSGVxdUw2eUQtQQ?oc=5\" target=\"_blank\">Logan Capital Management Inc. Reduces Holdings in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-28T10:07:25+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen’s New Prostate Cancer Study: A Potential Game-Changer? - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQaWZPcDR4ZjkwVGdIWlJrSWtLVXdSR3plOUpIdThnWjBtRjNfbTNNSWVCWHVUVHpkWXJxRFBSR3RyOHVidTdjTkpXTzJTMjdKbG9SNlltaGZLbGVhdjY2c1NqR1RwbVowMzNZeHJvWmNlTzRTMVZYdHhjVU55TWRzT3NYTWhad1Z6aGZSU29iVG1mUHVpZUlTWG9hVXJwNG96VVhBek9odUNVSUN0UVZ5VQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxQaWZPcDR4ZjkwVGdIWlJrSWtLVXdSR3plOUpIdThnWjBtRjNfbTNNSWVCWHVUVHpkWXJxRFBSR3RyOHVidTdjTkpXTzJTMjdKbG9SNlltaGZLbGVhdjY2c1NqR1RwbVowMzNZeHJvWmNlTzRTMVZYdHhjVU55TWRzT3NYTWhad1Z6aGZSU29iVG1mUHVpZUlTWG9hVXJwNG96VVhBek9odUNVSUN0UVZ5VQ?oc=5\" target=\"_blank\">Amgen’s New Prostate Cancer Study: A Potential Game-Changer?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-27T22:58:33+00:00",
      "source": "TipRanks"
    }
  ],
  "product_launches": [
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-27",
      "close": 291.1600036621094
    },
    "history": [
      {
        "date": "2025-10-17",
        "close": 298.80999755859375
      },
      {
        "date": "2025-10-20",
        "close": 303.3299865722656
      },
      {
        "date": "2025-10-21",
        "close": 301.1400146484375
      },
      {
        "date": "2025-10-22",
        "close": 295.9800109863281
      },
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      }
    ],
    "name": "Amgen Inc."
  }
}